EQUR
Price:
$0.0002
Market Cap:
$6.91K
E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.
Industry
Medical - Devices
IPO Date
1994-10-31
Stock Exchange
OTC
Ticker
EQUR
According to E-Qure Corp.’s latest financial reports and current stock price. The company's current ROE is 175.41%. This represents a change of 326.08% compared to the average of 41.17% of the last 4 quarters.
The mean historical ROE of E-Qure Corp. over the last ten years is 36.89%. The current 175.41% ROE has changed 375.52% with respect to the historical average. Over the past ten years (40 quarters), EQUR's ROE was at its highest in in the December 2013 quarter at 2.73%. The ROE was at its lowest in in the June 2017 quarter at -7936.17%.
Average
36.89%
Median
52.30%
Minimum
-1828.86%
Maximum
3.01%
Discovering the peaks and valleys of E-Qure Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.59%
Maximum Annual ROE = 3.01%
Minimum Annual Increase = -476.70%
Minimum Annual ROE = -1828.86%
| Year | ROE | Change |
|---|---|---|
| 2020 | 144.68% | -15.54% |
| 2019 | 171.29% | -114.52% |
| 2018 | -1179.75% | -476.70% |
| 2017 | 313.18% | -230.74% |
| 2016 | -239.54% | 87.82% |
| 2015 | -127.54% | -93.03% |
| 2014 | -1828.86% | -160.74% |
| 2013 | 3.01% | 3.59% |
| 2012 | 81.64% | 255.51% |
| 2011 | 22.96% | -122.96% |
The current ROE of E-Qure Corp. (EQUR) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-287.93%
5-year avg
-158.03%
10-year avg
36.89%
E-Qure Corp.’s ROE is less than Gene Biotherapeutics, Inc. (12.69%), less than Gelesis Holdings, Inc. (31.43%), less than EastWest Bioscience Inc. (668.97%), less than Nanomix Corporation (128.37%), less than Allied Healthcare Products, Inc. (0%), less than NeonMind Biosciences Inc. (366.65%), less than Capha Pharmaceuticals Inc. (9.55%), less than Acacia Diversified Holdings, Inc. (138.70%), less than MobileSmith, Inc. (225.88%), less than American Bio Medica Corporation (85.90%),
| Company | ROE | Market cap |
|---|---|---|
| 12.69% | $6.49K | |
| 31.43% | $7.33K | |
| 668.97% | $7.78K | |
| 128.37% | $9.80K | |
| 0% | $4.01K | |
| 366.65% | $8.54K | |
| 9.55% | $6.44K | |
| 138.70% | $5.43K | |
| 225.88% | $8.52K | |
| 85.90% | $4.81K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like E-Qure Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like E-Qure Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is E-Qure Corp.'s ROE?
How is the ROE calculated for E-Qure Corp. (EQUR)?
What is the highest ROE for E-Qure Corp. (EQUR)?
What is the 3-year average ROE for E-Qure Corp. (EQUR)?
What is the 5-year average ROE for E-Qure Corp. (EQUR)?
How does the current ROE for E-Qure Corp. (EQUR) compare to its historical average?